• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化心脏补片与炎症宿主细胞之间的动态相互作用。

Optimizing dynamic interactions between a cardiac patch and inflammatory host cells.

机构信息

Department of Biomedical Engineering, Columbia University, New York, N.Y., USA.

出版信息

Cells Tissues Organs. 2012;195(1-2):171-82. doi: 10.1159/000331392. Epub 2011 Oct 12.

DOI:10.1159/000331392
PMID:21996612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3325606/
Abstract

Damaged heart muscle has only a minimal ability for regeneration following myocardial infarction in which cardiomyocytes are lost to ischemia. The most clinically promising approach to regeneration of cardiac muscle currently under investigation is that of injecting cardiogenic repair cells or implanting a preformed tissue-engineered patch. While major advances are being made in the derivation of functional human cardiomyocytes and the development of tissue-engineering modalities for cardiac repair, the host environment into which the repair cells are placed is largely overlooked. Within seconds of myocardial ischemia, hypoxia sets in in the myocardium and the inflammatory response starts, characterized by rapid deployment of circulating cells and the release of paracrine and autocrine signals. Therefore, the inflammatory conditions under which these interactions take place, the design of the scaffold material used, and the maturity of the implanted cells will determine the outcomes of any stem cell-based therapy. We discuss here the interactions between implanted and inflammatory cells of the host, which are critical for the design of effective heart repair therapies.

摘要

心肌梗死后,心肌细胞因缺血而死亡,受损的心肌仅有极微弱的再生能力。目前,在心肌再生领域最有临床应用前景的方法是注射成心肌修复细胞或植入预先构建的组织工程贴片。虽然在获得功能型人类心肌细胞和开发心脏修复的组织工程方式方面取得了重大进展,但人们在很大程度上忽视了修复细胞所处的宿主环境。心肌缺血发生后的几秒钟内,心肌就会出现缺氧,炎症反应开始,其特征是循环细胞的快速募集以及旁分泌和自分泌信号的释放。因此,这些相互作用发生的炎症条件、所用支架材料的设计以及植入细胞的成熟度将决定任何基于干细胞的治疗的结果。我们在这里讨论了宿主植入细胞和炎症细胞之间的相互作用,这对于设计有效的心脏修复疗法至关重要。

相似文献

1
Optimizing dynamic interactions between a cardiac patch and inflammatory host cells.优化心脏补片与炎症宿主细胞之间的动态相互作用。
Cells Tissues Organs. 2012;195(1-2):171-82. doi: 10.1159/000331392. Epub 2011 Oct 12.
2
Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model.接种人诱导多能干细胞来源心肌细胞的组织工程心脏补片促进了大鼠模型中宿主心肌细胞的再生。
J Cardiothorac Surg. 2016 Dec 1;11(1):163. doi: 10.1186/s13019-016-0559-z.
3
Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts.组织工程化心肌细胞片层内的内皮细胞共培养可增强缺血心脏的新生血管形成并改善心脏功能。
Circulation. 2008 Sep 30;118(14 Suppl):S145-52. doi: 10.1161/CIRCULATIONAHA.107.757286.
4
Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts.通过心肌内注射与心外膜注射增强梗死大鼠心脏中工程化人心肌的电整合
PLoS One. 2015 Jul 10;10(7):e0131446. doi: 10.1371/journal.pone.0131446. eCollection 2015.
5
Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue.无支架血管化人心脏肌肉组织的生理功能与移植
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16568-73. doi: 10.1073/pnas.0908381106. Epub 2009 Sep 17.
6
Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation.工程化心脏组织补片在心外膜植入后保持结构和电性能。
Biomaterials. 2018 Mar;159:48-58. doi: 10.1016/j.biomaterials.2018.01.002. Epub 2018 Jan 3.
7
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function.多能干细胞衍生的具有先进结构和功能的心肌组织贴片。
Biomaterials. 2011 Dec;32(35):9180-7. doi: 10.1016/j.biomaterials.2011.08.050. Epub 2011 Sep 8.
8
Magnetic Resonance Imaging of Cardiac Strain Pattern Following Transplantation of Human Tissue Engineered Heart Muscles.人类组织工程心肌移植后心脏应变模式的磁共振成像
Circ Cardiovasc Imaging. 2016 Nov;9(11). doi: 10.1161/CIRCIMAGING.116.004731.
9
Cardiac tissue engineering: a clinical perspective.心脏组织工程:临床视角
Future Cardiol. 2007 Jul;3(4):435-45. doi: 10.2217/14796678.3.4.435.
10
Cardiac stem cells and their roles in myocardial infarction.心肌梗死后的心脏干细胞及其作用。
Stem Cell Rev Rep. 2013 Jun;9(3):326-38. doi: 10.1007/s12015-012-9421-4.

引用本文的文献

1
In Vitro Modulation of Spontaneous Activity in Embryonic Cardiomyocytes Cultured on Poly(vinyl alcohol)/Bioglass Type 58S Electrospun Scaffolds.聚(乙烯醇)/58S型生物活性玻璃电纺支架培养的胚胎心肌细胞自发活动的体外调节
Nanomaterials (Basel). 2024 Feb 17;14(4):372. doi: 10.3390/nano14040372.
2
Engineering Myocardium for Heart Regeneration-Advancements, Considerations, and Future Directions.用于心脏再生的工程化心肌——进展、考量及未来方向
Front Cardiovasc Med. 2020 Oct 15;7:586261. doi: 10.3389/fcvm.2020.586261. eCollection 2020.
3
attenuates cardiac injury without lowering cholesterol in low-density lipoprotein receptor-deficient mice fed standard chow.在给予标准饲料的低密度脂蛋白受体缺陷型小鼠中,它可减轻心脏损伤,而不会降低胆固醇。
Am J Physiol Heart Circ Physiol. 2020 Jul 1;319(1):H32-H41. doi: 10.1152/ajpheart.00569.2019. Epub 2020 May 15.
4
Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.单核细胞与淋巴细胞比值和中性粒细胞与淋巴细胞比值联合对行直接经皮冠状动脉介入治疗的非 ST 段抬高型心肌梗死患者预后的预测价值:一项回顾性队列研究。
BMJ Open. 2018 Oct 18;8(10):e023459. doi: 10.1136/bmjopen-2018-023459.
5
A Regenerative Cardiac Patch Formed by Spray Painting of Biomaterials onto the Heart.通过将生物材料喷涂到心脏上形成的再生心脏补片。
Tissue Eng Part C Methods. 2017 Mar;23(3):146-155. doi: 10.1089/ten.TEC.2016.0492. Epub 2017 Feb 15.
6
Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?心肌再生的组织工程策略:去细胞支架与细胞支架?
Tissue Eng Part B Rev. 2016 Dec;22(6):438-458. doi: 10.1089/ten.TEB.2015.0523. Epub 2016 Jul 21.
7
Tissue-Engineering for the Study of Cardiac Biomechanics.用于心脏生物力学研究的组织工程
J Biomech Eng. 2016 Feb;138(2):021010. doi: 10.1115/1.4032355.
8
Cardiomyocytes induce macrophage receptor shedding to suppress phagocytosis.心肌细胞诱导巨噬细胞受体脱落以抑制吞噬作用。
J Mol Cell Cardiol. 2015 Oct;87:171-9. doi: 10.1016/j.yjmcc.2015.08.009. Epub 2015 Aug 24.
9
HLA Class I Depleted hESC as a Source of Hypoimmunogenic Cells for Tissue Engineering Applications.HLA I类缺失的人胚胎干细胞作为用于组织工程应用的低免疫原性细胞来源。
Tissue Eng Part A. 2015 Oct;21(19-20):2559-71. doi: 10.1089/ten.TEA.2015.0105. Epub 2015 Sep 10.
10
Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration.用于定制体内功能和心脏再生的受生理启发的心脏支架。
Biomed Mater. 2015 May 13;10(3):034003. doi: 10.1088/1748-6041/10/3/034003.

本文引用的文献

1
Bioengineering heart muscle: a paradigm for regenerative medicine.生物工程心脏肌肉:再生医学的范例。
Annu Rev Biomed Eng. 2011 Aug 15;13:245-67. doi: 10.1146/annurev-bioeng-071910-124701.
2
Biomimetic platforms for human stem cell research.仿生学平台在人类干细胞研究中的应用。
Cell Stem Cell. 2011 Mar 4;8(3):252-61. doi: 10.1016/j.stem.2011.02.014.
3
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines.阶段特异性激活素/ nodal 和 BMP 信号转导促进小鼠和人多能干细胞系的心脏分化。
Cell Stem Cell. 2011 Feb 4;8(2):228-40. doi: 10.1016/j.stem.2010.12.008.
4
Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.多能干细胞的心肌细胞分化及其在心脏疾病模型中的应用。
Biochem J. 2011 Feb 15;434(1):25-35. doi: 10.1042/BJ20101707.
5
Modelling the long QT syndrome with induced pluripotent stem cells.利用诱导多能干细胞构建长 QT 综合征模型。
Nature. 2011 Mar 10;471(7337):225-9. doi: 10.1038/nature09747. Epub 2011 Jan 16.
6
Induced pluripotent stem cells in long-QT syndrome.
N Engl J Med. 2011 Jan 13;364(2):181; author reply 181-2. doi: 10.1056/NEJMc1012529.
7
Macrophage and dendritic cell phenotypic diversity in the context of biomaterials.生物材料背景下的巨噬细胞和树突状细胞表型多样性。
J Biomed Mater Res A. 2011 Jan;96(1):239-60. doi: 10.1002/jbm.a.32971. Epub 2010 Nov 10.
8
Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats.人胚胎干细胞衍生的心肌细胞在大鼠慢性梗死后可移植,但不能改变心脏重构。
J Mol Cell Cardiol. 2010 Dec;49(6):941-9. doi: 10.1016/j.yjmcc.2010.09.008. Epub 2010 Sep 18.
9
Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro.生物材料形貌在体内改变愈合过程,并在体外改变单核细胞/巨噬细胞的激活状态。
J Biomed Mater Res A. 2010 Nov;95(2):649-57. doi: 10.1002/jbm.a.32893.
10
Proangiogenic scaffolds as functional templates for cardiac tissue engineering.促血管生成支架作为心脏组织工程的功能模板。
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15211-6. doi: 10.1073/pnas.1006442107. Epub 2010 Aug 9.